Effervescent Tablets Market

By Product;

Medication and Supplements

By Method;

Dry Methods and Wet Granulation

By Indication;

Pain Management, Diuretics, Gastric Disorders, Respiratory Diseases and Others

By Application;

Dental Products, Dietary Supplements, Pharmaceutical and Others

By End User;

Hospitals, Specialty Clinics, Homecare and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn066552434 Published Date: September, 2025 Updated Date: November, 2025

Effervescent Tablets Market Overview

Global Effervescent Tablet Market (USD Million)

Effervescent Tablet Market was valued at USD 34,523.85 million in the year 2024. The size of this market is expected to increase to USD 59,939.08 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.2%.


Effervescent Tablets Market

*Market size in USD million

CAGR 8.2 %


Study Period2025 - 2031
Base Year2024
CAGR (%)8.2 %
Market Size (2024)USD 34,523.85 Million
Market Size (2031)USD 59,939.08 Million
Market ConcentrationMedium
Report Pages347
34,523.85
2024
59,939.08
2031

Major Players

  • Bayer Ag
  • GlaxoSmithKline PLC,
  • Prestige Brands, Inc
  • Nuun and Company Inc.
  • DMK Group
  • Herbalife International Of America, Inc

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Effervescent Tablets Market

Fragmented - Highly competitive market without dominant players


The Effervescent Tablets Market is experiencing strong growth as consumers adopt convenient and fast-dissolving healthcare solutions. Nearly 55% of individuals now prefer these tablets because of their quick absorption and ease of use. Their expanding role in nutraceuticals, pharmaceuticals, and wellness products is reshaping traditional dosage forms with innovative alternatives.

Rising Consumer Preference
Growing reliance on nutraceutical supplements has boosted demand, with about 60% of supplement users opting for effervescent forms. Their pleasant taste, reduced swallowing difficulties, and rapid disintegration make them appealing to children and elderly groups, leading to broader adoption across healthcare segments.

Technological Advancements
Continuous research and development has improved tablet stability, flavor quality, and nutritional combinations. More than 45% of manufacturers are introducing advanced formulations enriched with vitamins, minerals, and electrolytes. These innovations expand product applications into functional beverages and fortified wellness products.

Healthcare and Lifestyle Trends
Increasing focus on preventive healthcare has significantly contributed to adoption. Close to 50% of consumers now seek products that support immunity, hydration, and daily wellness. Effervescent tablets deliver on-the-go solutions that align seamlessly with fast-paced modern lifestyles, strengthening their demand.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Method
    3. Market Snapshot, By Indication
    4. Market Snapshot, By Application
    5. Market Snapshot, By End User
    6. Market Snapshot, By Region
  4. Effervescent Tablets Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Regulatory Challenges
        2. Product Stability Concerns
        3. Environmental Impact Awareness
        4. Restraints
        5. Increasing Consumer Preference for Convenience
        6. Growing Demand for Nutritional Supplements
        7. Technological Advancements in Formulation
      2. Opportunities
        1. Expansion into Emerging Markets
        2. Diversification into Therapeutic Areas
        3. Strategic Collaborations and Partnerships
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Effervescent Tablets Market, By Product, 2021 - 2031 (USD Million)
      1. Medication
      2. Supplements
    2. Effervescent Tablets Market, By Method, 2021 - 2031 (USD Million)
      1. Dry Methods
      2. Wet Granulation
    3. Effervescent Tablets Market, By Indication, 2021 - 2031 (USD Million)
      1. Pain Management
      2. Diuretics
      3. Gastric Disorders
      4. Respiratory Diseases
      5. Others
    4. Effervescent Tablets Market, By Application, 2021 - 2031 (USD Million)
      1. Dental Products
      2. Dietary Supplements
      3. Pharmaceutical
      4. Others
    5. Effervescent Tablets Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Specialty Clinics
      3. Homecare
      4. Others
    6. Effervescent Tablets Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Bayer AG
      2. Pfizer Inc.
      3. Novartis AG
      4. GSK plc
      5. Reckitt Benckiser Group PLC
      6. Perrigo Company plc
      7. Bliss GVS Pharma Limited
      8. CHIESI SAS
      9. Swisse Wellness PTY LTD
      10. Herbalife International of America, Inc.
      11. S. G. Biopharm Pvt. Ltd
      12. Vovantis Laboratories
      13. Alpex
      14. SCITECH
      15. Viatris
  7. Analyst Views
  8. Future Outlook of the Market